Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 10/20 | 0.44 |
| ▸ | EDNRB | P24530 | 9/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6579920 | 0.97 | EDNRA (0.46) | EDNRAEDNRBKDM4EALDH1A1HPGD | |
| SCHEMBL6580278 | 0.92 | EDNRA (0.45) | EDNRAEDNRBKDM4EALDH1A1HPGD | |
| SCHEMBL8524654 | 0.90 | SMN1; SMN2 (0.39) | EDNRAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL7494883 | 0.89 | EDNRA (0.46) | EDNRAEDNRBKDM4EALDH1A1HPGD | |
| SCHEMBL6582508 | 0.89 | EDNRA (0.43) | EDNRAEDNRBALDH1A1 | |
| SCHEMBL6582681 | 0.89 | KDM4E (0.40) | EDNRAEDNRBKDM4EALDH1A1HPGD | |
| SCHEMBL7495951 | 0.89 | EDNRA (0.46) | EDNRAEDNRBKDM4EALDH1A1HPGD | |
| SCHEMBL6582430 | 0.88 | EDNRA (0.43) | EDNRAEDNRBALDH1A1SMN1; SMN2 | |
| SCHEMBL8434768 | 0.87 | EDNRA (0.52) | EDNRAEDNRBKDM4EALDH1A1HPGD | |
| SCHEMBL8432517 | 0.87 | EDNRA (0.42) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0804435-B1 | NOVEL IMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, NOVEL INTERMEDIATES THUS OBTAINED, MEDICINAL APPLICATIONS OF SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | AVENTIS PHARMA SA (FR) | 2004-03-10 | — | — | EP | claimed |